Biocon Biologics expands R&D footprint

Biologics |  News | 0 Comment | 24 Sep, 2019

Asia’s premier biopharmaceuticals company, has announced that its subsidiary, Biocon Biologics, has acquired R&D capital assets for a 60,000 sq. ft  state-of-the-art ‘b...Read more

I-Mab gets IND approval for TJC4 antibody

Biologics |  News | 0 Comment | 15 Jul, 2019

I-Mab Biopharma ("I-Mab"), a clinical stage biotech company exclusively focusing on discovery and development of innovative biologics in immuno-oncology and autoimmune diseases, announces t...Read more

Potential treatment strategies for human cancer uncovered in bats

Biologics |  News | 0 Comment | 02 Jul, 2019

Researchers from Duke-NUS Medical School, Singapore have uncovered a potential mechanism behind cancer suppression in bats that may lead to future therapies for human cancers. The research ...Read more

NMPA accepts NDA for biosimilar product candidate of Rituximab

Biologics |  News | 0 Comment | 27 Jun, 2019

Innovent Biologics and Eli Lilly and Company have jointly announced that the National Medical Products Administration (NMPA) has accepted its new drug application (NDA) for IBI301, a co-dev...Read more

Biocon Biologics receive EU GMP Certification

Biologics |  News | 0 Comment | 14 Jun, 2019

Biocon has received the Certificate of GMP compliance from EMA for its Biologics Drug Product (DP) as well as Drug Substance (DS) facilities at Biocon Park, Bengaluru. These facilities, us...Read more

NTU team explore binding secrets of superglue protein

Biologics |  News | 0 Comment | 06 Jun, 2019

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have pinpointed how a special class of plant-derived enzymes, known as peptide ligases, work to join proteins tog...Read more

Alphamab completes $60 M Series B Financing

Biologics |  News | 0 Comment | 29 May, 2019

Alphamab Oncology, a leading biopharmaceutical company based in China dedicated to global development of innovative biologics for cancer therapy, has completed a US$60 million Ser...Read more

Signalling protein may unleash the potential of drug-based therapies to treat hyperparathyroidism

Biologics |  News | 0 Comment | 28 May, 2019

Researchers at Duke-NUS Medical School, Singapore have discovered “Sema3d”, a signalling protein that appears to protect parathyroid glands from excessive activity providing ins...Read more

EMA accepts Prestige Biopharma's MAA for review

Biologics |  News | 0 Comment | 28 May, 2019

Prestige BioPharma has announced that European Medicines Agency (EMA) has validated and accepted for review the Marketing Authorization Application (MAA) for its trastuzumab biosimilar...Read more

Translational research led by Singapore scientists uncovers new treatment for fatty liver disease

Biologics |  News | 0 Comment | 24 May, 2019

A team of researchers at Singapore that deactivating a specific protein − interleukin 11 (IL11) – with drugs called therapeutic antibodies, reverses inflammation and scarring of...Read more

WuXi Biologics commences construction of center for Innovative Biologics

Biologics |  News | 0 Comment | 17 May, 2019

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that ...Read more

Takeda's BLA for Vedolizumab gets approval by U.S. FDA

Biologics |  News | 0 Comment | 14 May, 2019

Takeda Pharmaceutical Company has announced that the U.S. Food & Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for a subcutaneous (SC) for...Read more

Evolve BioSystems launches Evivo in Hong Kong, Singapore

Biologics |  News | 0 Comment | 07 May, 2019

Evolve BioSystems, makers of Evivo® baby probiotic, announced that its flagship consumer product Evivo is available in Hong Kong and Singapore. The introductio...Read more

New chemical probe for visualising brain immune cells

Biologics |  News | 0 Comment | 03 May, 2019

Researchers in South Korea and Singapore have, for the first time, have developed a chemical probe that enables live-imaging of a type of immune cells in the brain, known as microglia, in a...Read more

Duke-NUS team reveals link between autism and antidepressants

Biologics |  News | 0 Comment | 30 Apr, 2019

An international team led by Duke-NUS Medical School has found a potential link between autistic-like behaviour in adult mice and exposure to a common antidepressant in the womb. They also ...Read more

Japanese scientists reveal potential of technology to detect cancer

Biologics |  News | 0 Comment | 29 Apr, 2019

Researchers at Okayama University in Japan have reported in the journal Sensors and Actuators B: Chemical that terahertz radiation can be used to rapidly detect makers for breast-cancer cel...Read more

A*Star, NEA & NCID develop diagnostic test for mosquito-borne diseases

Biologics |  News | 0 Comment | 24 Apr, 2019

Scientists from Singapore's Agency for Science, Technology and Research (A*STAR), in collaboration with the Environmental Health Institute (EHI) of the National Environment Agency (NEA), an...Read more

A*STAR & Duke-NUS unveils the map to design treatment for dengue and zika viruses

Biologics |  News | 0 Comment | 24 Apr, 2019

Scientists from the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS), together with scientists from Duke-NUS Medical School and A*STAR’...Read more